TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

10 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

14 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

11 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

07 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

27 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)

07 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

07 фев 2024 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

02 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

04 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

29 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer

27 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates

14 ноя 2023 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023

13 ноя 2023 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

09 ноя 2023 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

03 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity

02 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming Investor Conferences

19 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia

16 окт 2023 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

03 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire